FibroBiologics, Inc. SEC filings FBLG
FibroBiologics, Inc. has 242 filings in SEC EDGAR's recent list, going back to Jan 31, 2023. Its latest annual report, Form ARS, was filed on May 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 31, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13D | Ownership over 5% (active) | Sep 17, 2026 | — |
| 4 | Insider transaction | Sep 15, 2026 | Sep 15, 2026 |
| 3 | Initial insider ownership | Sep 1, 2026 | Aug 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Jul 16, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 23, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| 4 | Insider transaction | May 4, 2026 | May 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 9, 2026 | — |
| 4 | Insider transaction | Mar 5, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 3, 2026 | Mar 2, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Dec 12, 2025 | Dec 11, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 17, 2025 | — |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 3 | Initial insider ownership | Jun 10, 2025 | Jun 9, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 6, 2025 | — |
| 4 | Insider transaction | May 27, 2025 | May 27, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 28, 2025 | Mar 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 29, 2025 | — |
| 4 | Insider transaction | Dec 30, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 27, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 5, 2024 | Dec 3, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 27, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 13, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 12, 2024 |
| 4 | Insider transaction | Aug 12, 2024 | Aug 12, 2024 |
| 3/A | Filing | Aug 12, 2024 | Jan 24, 2024 |
| 3/A | Filing | Aug 12, 2024 | Jan 24, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 1, 2024 |
| 3 | Initial insider ownership | Mar 6, 2024 | Mar 1, 2024 |
| 3 | Initial insider ownership | Feb 15, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 13, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 13, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 7, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 7, 2024 | Jan 24, 2024 |
| 3 | Initial insider ownership | Feb 7, 2024 | Jan 24, 2024 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FBLG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Houston, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1958777
- Former names
- FibroBiologics Inc. (until Feb 6, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.